In Brief
African trypanosomes, pathogens responsible for human sleeping sickness, exchange virulence factors through extracellular vesicles formed via membrane nanotubes. These factors facilitate resistance to host innate immune responses and cause anemia.
INTRODUCTION
Bacteria and eukaryotic cells use extracellular vesicles (EVs) as vehicles for delivery of modulatory proteins, lipids and nucleic acids to neighboring cells (Schorey et al., 2015; Yá ñ ez-Mó et al., 2015) . Extracellular vesicles generally fall into two classes: (1) exosomes produced in the exocytic pathways and generally associated with the formation of multivesicular bodies (MVBs), and (2) ectosomes formed by budding of the plasma membrane. Both carry effector proteins and nucleic acids (Schorey et al., 2015; Wood and Rosenbaum, 2015) . Functions proposed for EVs include transfer of drug resistance, growth regulation, quorum sensing, immune regulation, developmental modulation, and neurotransmission (Remis et al., 2014) . In addition, several human diseases including cancer, atherosclerosis, neurodegeneration, as well as viral and parasite infections are affected by EV production. A clear and defining function of EVs is the delivery of modulatory molecules to other cells within and between species. The range of functions attributed to EVs is reflected in diverse mechanisms of EV biogenesis and composition (Schorey et al., 2015) .
The kinetoplastidae is a diverse group of eukaryotic microbes responsible for several important human and animal diseases including African sleeping sickness (Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense), Chagas disease (Trypanosoma cruzi), Kala azar (Leishmania donovani), and Nagana in cattle (Trypanosoma brucei brucei). T. cruzi and Leishmania spp. have been shown to release EVs that interact with host cells and modulate immune responses (Marcilla et al., 2014) . Other eukaryote pathogens also produce EVs. EVs derived from Plasmodium falciparum-infected erythrocytes promote parasite differentiation and regulate immune cells within the mammalian host (Mantel et al., 2013; Regev-Rudzki et al., 2013) . The urogenital tract parasite Trichomonas vaginalis produces EVs that alter adherence to host cells and modulate the host immune response to infection (Twu et al., 2013) .
Humans and other higher primates are innately immune to many African trypanosomes by virtue of circulating trypanosome lytic factors (TLF). Human pathogenic T. b. rhodesiense circumvents TLF activity through expression of a virulence factor, the serum-resistance associated protein (SRA) (De Greef and Hamers, 1994) . The mechanism of SRA involves binding to apolipoprotein L-1 (ApoL-1), a pore forming toxin within TLF ( Vanhamme et al., 2003) . Binding, uptake, and intracellular trafficking of TLF to early endosomes of T. b. rhodesiense leads to co-localization of SRA and TLF, facilitating the neutralization of ApoL-1 activity (Stephens and Hajduk, 2011) . Transfection of T. b. brucei with the gene encoding SRA or co-infection of tsetse flies with T. b. rhodesiense and T. b. brucei allows for transfer of the gene encoding SRA to T. b. brucei and confers resistance to TLF (Gibson et al., 2015; Xong et al., 1998) . Direct transfer of this virulence protein between trypanosomes has not been reported.
Like many extracellular pathogens, African trypanosome infection initially elicits a type 1 immune response that includes expression of inflammatory cytokines and activation of myeloid cells. These host immune responses have been implicated in the pathology of trypanosomiasis-associated anemia (Stijlemans et al., 2015) . Anemia is markedly severe during acute infection and is the major cause of cattle death due to Nagana (Naessens, 2006) . Recently, erythrophagocytosis by activated liver and spleen myeloid cells has been identified as a major contributor to erythrocyte clearance. In addition, the lipid composition of erythrocytes is altered during trypanosome infection and these erythrocytes are preferentially phagocytosed by the host's myeloid cells (Stijlemans et al., 2015) . While host responses that contribute to anemia have been characterized, the parasite factors that elicit erythrocyte clearance are unknown.
Here, we describe a dynamic class of membrane nanotubes that bud from the trypanosome flagellar membrane and vesicularize to form EVs. The proteome of these EVs is enriched for specific flagellar membrane proteins and contains a number of proteins implicated in virulence and persistence within the host. Functionally, we show that T. brucei EVs fuse with target lipid bilayers, including the flagellar pocket of neighboring trypanosomes, resulting in transfer and internalization of lipids and proteins. Transferred proteins retain activity since T. b. rhodesiense EVs transfer SRA to T. b. brucei resulting in resistance to TLF. T. brucei EVs are also highly fusogenic with host erythrocyte membranes, altering the physical properties of the membrane and causing erythrocyte clearance from circulation. We postulate that this causes anemia during animal and human infection by African trypanosomes. Our findings show that EVs contribute to the complexity of African trypanosomiasis through the transfer of virulence factors between parasites and inadvertent interaction with host cells, which has a profound effect on disease.
RESULTS AND DISCUSSION
Flagellar Membrane Budding Gives Rise to Nanotubes and EVs in T. brucei Exchange of metabolites, nucleic acids, and proteins in bacteria can take place over short and long distances via the formation of membrane nanotubes between individual bacterium and production and delivery of EVs (Dubey and Ben-Yehuda, 2011 ). Cell-cell communication occurs in the eukaryotic pathogen T. b. brucei as demonstrated by quorum sensing-mediated differentiation into the tsetse fly transmissible short-stumpy developmental form in the mammalian bloodstream (Mony et al., 2014) and social motility exhibited by procyclic forms in the insect vector midgut (Oberholzer et al., 2010) . The molecular mechanisms underlying these communication processes in African trypanosomes have not yet been identified.
Visualization of bloodstream form (BF) T. b. brucei by differential interference contrast (DIC) video microscopy revealed the presence of highly dynamic filamentous structures (2-20 mm) extending from the posterior end of some cells ( Figure 1A ). These structures resembled previously described thread-like appendages, later called plasmanemes, associated with BF African trypanosomes (Babudieri and Tomasini, 1962; Schepilewsky, 1912; Vickerman and Luckins, 1969) . Occasionally filaments appeared to make connections with the posterior ends of other trypanosomes and if unattached become highly branched (Figure 1A) . These structures were largely disregarded due to lack of detection from blood of infected mice (Ellis et al., 1976; Wright et al., 1970) . To determine if these structures were physiologically relevant, we performed DIC video microscopy of infected mouse blood. Similar filamentous structures were also visible on T. brucei in the blood of infected mice ( Figures 1B and  S1A ). The formation of the filaments in vitro was stimulated by stress from RNAi against an essential BF protein or by addition of complement active serum to growth medium ( Figure S1B ) (Sykes et al., 2015) . These induction mechanisms allowed us to investigate filament biogenesis.
Live imaging of BF T. brucei labeled with the membrane binding dye octadecyl rhodamine B (R18) suggested that filaments were bounded by a lipid membrane and led us to rename the plasmanemes ''membrane nanotubes'' to better reflect their structure and composition ( Figure 1C ; Movies S1 and S2). Observations of nanotubes connecting cells showed these interactions were stable over long distances (>20 mm) and highly dynamic, releasing and forming new connections with several cells over time ( Figure 1D ; Movie S3). When visualized by negative stain transmission electron microscopy (TEM), nascent nanotubes showed a continuous membrane ( Figures 1E and S1C ), consistent with previous observations using negative stain and thin section TEM (Frevert and Reinwald, 1988; Vickerman and Luckins, 1969) . Although it has been shown previously that short stumpy T. brucei produce ''secretory-filaments,'' we restricted our studies to exponentially growing long slender BF T. brucei (Ellis et al., 1976) . Nanotubes were restricted to the cell posterior, suggesting a polarized point of origin. TEM of thin sections revealed membrane budding from the flagellum, with similar characteristics to the adjacent flagellar membrane (Figures 1F and S1D) , and three-dimensional reconstruction of serial sections showed that protrusion of the flagellar membrane gave rise to a tubular structure lacking the axoneme and paraflagellar rod ( Figure 1G ; Movie S4). These observations suggested that T. brucei nanotubes developed from budding of the flagellar membrane and extended for at least a short distance parallel to the flagellum. Longitudinal sections through nanotubes revealed repeating spherical units resembling ''beads on a string'' outside the flagellar pocket at the cell surface ( Figure 2A ). The average diameter of a ''bead'' was 100 nm ( Figure 2B ). The vesicular appearance of trypanosome nanotubes resembles the vesicle chains that dissociate to produce free EVs in the bacterium Myxococcus xanthus (Dubey and Ben-Yehuda, 2011) . These observations are similar to previous reports from trypanosomes (Babudieri and Tomasini, 1962; Ellis et al., 1976; Frevert and Reinwald, 1988; Schepilewsky, 1912) . Indeed, scanning electron microscopy revealed trypanosome-associated vesicles consistent in size with nanotube beads ( Figure 2C ). Using DIC video microscopy, we observed the dynamics of formation, release and disassociation of a nanotube into diffusible EVs (Figure 2D ; Movie S5). Release from nanotubes allowed us to purify, characterize, and investigate the cellular interactions of trypanosome EVs derived from exponentially growing cells that have not been stimulated for nanotube formation.
The EV Proteome Is Enriched in Flagellar Membrane
Proteins and Parasite Virulence Factors When viewed by negative stain, TEM purified EVs appear as unilamellar vesicles 70-80 nm in diameter, consistent with the size of nanotube-associated beads (Figure 2E, upper panel) . TEM thin section analysis of purified EVs revealed membrane-bound vesicles of 80 nm in size with a 10-nm thick membrane (Figures 2E, lower panel, and S1E) with similar characteristics to cell plasma membrane ( Figure S1F ). Nanoparticle tracking analysis revealed a major population of vesicles with a mean diameter of 81 nm and a minor population 165 nm in diameter ( Figure 2F ). Purified EVs showed a different SDS-PAGE protein profile than total cell ( Figure 2G ). Proteomic analysis of EVs revealed 156 proteins from diverse functional classes (Table S1 ) and several were confirmed by western blotting, including the expressed variant surface glycoprotein (VSG 221), Hsp-70, glycerol kinase, and aldolase ( Figure 2H ). Similar to observations from Leishmania spp., we detected ribosomal proteins in the T. brucei EV proteome (Silverman et al., 2010) . Although it is not uncommon to screen out proteins based on high isoelectric point, removing See also Figures S1E and S1F , Tables S1 and S2 , and Movie S5.
many ribosomal proteins, we performed an analysis on the complete/unfiltered 156 proteins ( Figure 2I ; Tables S1 and S2 ) (Broadhead et al., 2006) . Comparison of the EV proteome with that of the flagellar surface and flagellar matrix showed significant overlap ( Figure 2I ) (Oberholzer et al., 2011) . Our analysis showed that 50 of 156 EV proteins were either flagellar matrix or membrane proteins representing 32% of the EV proteome.
In addition, we found only minor similarity with the glycosome (2%) and mitochondrial (2%) proteomes (Gü ther et al., 2014; Panigrahi et al., 2009 ) ( Figure 2I ; Table S2 ), which is proportionally similar when compared to the total proteome; therefore, EVs from T. b. brucei BFs are not enriched with proteins from these two organelles. Ten of these proteins have previously been colocalized by fluorescence microcopy and were shown to be flagellar/flagellar-associated (Table S2 ). While the EVs appear homogeneous in size and morphology, they may be derived from multiple mechanisms of origin. Enrichment of EVs with flagellar proteins is consistent with a population of EVs being derived from nanotubes that form by budding of the flagellar membrane. We observed that in addition to abundant proteins such as VSG more than 20% of the EVs composition was from low abundance proteins (Table S2 ) (Jensen et al., 2014) . Among these minor proteins were several flagellar proteins, including calflagin (CF), adenylate cyclase (GRESAG4), glycosylphosphatidylinositol phospholipase C (GPI-PLC), and metacaspase 4 (MCA4), that contribute to the virulence of T. brucei in the mammalian host (Table S2 ) (Emmer et al., 2010; Proto et al., 2011; Salmon et al., 2012; Webb et al., 1997 (Oli et al., 2006) , and western blots demonstrated the presence of SRA in these preparations ( Figure 2J ). The diversity of virulence factors detected in the EV proteome suggests that the flagellum may serve as part of a sorting pathway for delivery of biologically active molecules to neighboring cells. Figures 3A and 3B) . T. b. brucei were incubated with SRA-Ty containing EVs at 37 C, washed to remove unbound EVs and fixed with paraformaldehyde. Fixed cells were either treated directly with anti-Ty antibody and a fluorescent secondary antibody ( Figure 3A ) or first treated with low concentrations of detergent (0.1% Triton X-100) to permeabilize the cells prior to addition of antibodies ( Figure 3B ). EV-treated wild-type T. b. brucei became SRA-Ty positive after detergent treatment, suggesting that EVs delivered SRA-Ty that accumulated in an intracellular location that was accessible to antibodies only following detergent permeabilization. Immunofluorescence microscopy indicated that SRA-Ty delivered by EVs was internalized by wild-type T. b. brucei and co-localized with concanavalin A (ConA) a marker for the trypanosome endocytic pathway ( Figures 3C and S2A-S2C ). Together, these data indicated that SRA from EVs was deposited in the endolysosomal system of recipient trypanosomes. Since SRA localizes to endosomes in T. b. rhodesiense and T. b. brucei SRA-Ty , these observations suggested EV transfer of SRA may protect recipient T. b. brucei from TLF killing (Stephens and Hajduk, 2011) .
There have been a number of reported human infections by non-human infectious species of trypanosomes (Truc et al., 2013) . While these may represent either misidentification of the parasite or genetic acquisition of TLF resistance, an alternative possibility is transfer of SRA to TLF susceptible trypanosomes during a dual infection with T. b. rhodesiense. Our discovery Figures 3E and 3F ).
While these co-cultivation studies were consistent with EV transfer of SRA to recipient cells, they did not exclude the possibility that diffusible, non-EV-associated SRA could cross the transwell membrane conferring TLF resistance to the recipient cells. To exclude this possibility, purified EVs were added directly to wild-type T. b. brucei ( Figure 3G) Figures 3H, 3I , and S2E). These data indicated that functional SRA was transferred by EVs to co-cultured trypanosomes leading to resistance to TLF.
Trypanosome EVs Are Highly Fusogenic and Rapidly Transfer Proteins and Lipids to Recipient Trypanosomes
Internalization of EV-associated SRA by recipient T. b. brucei could be by receptor-mediated or fluid-phase endocytosis of EVs or may reflect direct fusion of EVs with the trypanosome plasma membrane. To determine the site of interaction and subsequent fate of EV proteins, we labeled purified trypanosome EVs with Alexa-Fluor594 and followed the binding and localization of these proteins in T. brucei. When endocytosis was blocked, by maintaining cells at 3 C, EV proteins accumulated in the flagellar pocket as indicated by co-localization with ConA ( Figure 4A ). Binding of EVs to the trypanosome flagellar pocket was nonsaturable, suggesting a receptor-independent process ( Figure S3A ). This T. brucei EV binding could not be competed away with unlabeled BF T. brucei EVs ( Figures S3B and S3C) or with EVs from a different life cycle stage ( Figures  S3D and S3E) , related kinetoplastid Leishmania tarentolae (Figures S3F and S3G) , or with human erythrocyte microvesicles ( Figures S3H-S3K ). After warming to 37 C, to allow endocytosis, both ConA and labeled EV proteins localized within endolysosomal vesicles ( Figure 4B) . T. b. brucei EVs bound and were taken up independent of the expressed VSG ( Figure S4A ) and subspecies of T. brucei ( Figure S4B ).
Since EV binding and uptake by T. b. brucei was receptor-independent and because EVs from other cell types have been shown to fuse with target cell membranes (Evans et al., 2012; Vidal and Hoekstra, 1995) , we asked whether T. brucei EVs were fusogenic. Trypanosome EVs were purified and labeled with a self-quenching concentration of the lipophilic fluorophore octadecyl rhodamine B (R18). When R18-labeled EVs were incubated with T. brucei, a time-dependent increase in fluorescence was observed, indicating dilution of the fluorophore and suggesting fusion of the EVs with T. brucei membranes ( Figure 4C ). When visualized by ImageStream flow-cytometry, the R18 signal appeared initially localized to the posterior ends of cells and subsequently spread over the entire surface of the cell ( Figures 4D,  4E , and S4C). These data are consistent with EVs fusing to the flagellar pocket membrane and rapid equilibration of EV lipids throughout the trypanosome membranes.
Trypanosome EVs Are Fusogenic with Artificial Liposomes and Mammalian Erythrocytes
To determine whether EV fusion was due to unique features of the flagellar pocket membrane of trypanosomes, purified R18-labeled T. b. brucei EVs were incubated with unlabeled 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) large unilamellar liposomes (LUV). A time-dependent increase in fluorescence was observed as R18 was diluted into the unlabeled LUV membranes due to fusion ( Figure 5A ). Trypsinization of EVs ablated fusion, but EVs retained R18 loading requiring detergent treatment for R18 release, indicating that a(n) exposed EV protein(s) was necessary for membrane fusion ( Figure 5A ). Since T. b. brucei is an extracellular parasite within the circulatory system, host erythrocytes would present abundant target membranes for EV fusion. Therefore, we investigated whether T. b. brucei EVs fuse with mammalian erythrocytes. Purified EVs, but not POPC LUV, fused with human erythrocyte ghosts and fusion was ablated by trypsinization of the EV ( Figure 5B ). Flow cytometry indicates that EVs fuse with intact erythrocytes and transfer R18 from EVs to erythrocytes ( Figure 5C ). Fluorescence microscopy of R18-EV-treated erythrocytes revealed a diffuse R18 signal spread over the surface of the cell ( Figure 5D ). Fusion also resulted in transfer of Alexa-Fluor-labeled EV proteins to erythrocytes ( Figure 5E ). Therefore, EVs facilitate transfer of trypanosome lipid and protein to host erythrocytes. To further address this possibility, BF T. b. brucei were labeled with R18, incubated with erythrocytes separated in 0.2 mm transwells and erythrocytes analyzed by flow cytometry ( Figure 5F ). Consistent with T. b. brucei EVs transfer, we found that erythrocytes became labeled with R18 under these conditions. Rifkin and Landsberger (1990) demonstrated that membrane-form VSG was transferred to erythrocytes co-cultured with T. b. brucei. Based on the presence of VSG in EVs and transfer of EV proteins to erythrocytes, we asked whether VSG is present on EV-treated erythrocytes. Immunofluorescence microscopy showed VSG on the surface of erythrocytes treated with T. b. brucei EVs ( Figure 6A ). This result was recapitulated when erythrocytes were co-incubated with T. b. brucei separated in transwells, again consistent with the biogenesis and fusion of EVs ( Figure 6B ). Based on these results, we postulate that fusogenic trypanosome EVs may serve as vehicles for pathogen-to-host cell transfer of membrane proteins.
T. b. brucei EV Fusion Modifies Erythrocytes and Causes Anemia
Because EV fusion incorporates exogenous proteins and lipids into erythrocytes, we investigated whether the physical properties of the plasma membrane were altered. Human erythrocytes treated with EVs were less sensitive to osmotic lysis (Figure 6C) . To more specifically define the EV-mediated changes to erythrocyte membranes, we probed plasma membrane lipid packing. Human erythrocytes incubated with EVs showed an increase in membrane rigidity as indicated by a narrowing and shift of the emission spectra of Laurdan toward shorter wavelengths ( Figure 6D) . Recently, it has been shown that erythrocyte lipid composition was altered during trypanosomiasis, and these cells were preferentially phagocytosed by myeloid cells (Stijlemans et al., 2015) . Incorporating parasite lipid via EV fusion may explain altered erythrocyte lipid composition.
Trypanosome infection elicits a severe loss of erythrocytes during acute phase infection that is independent of B cell response or IgM (Magez et al., 2008) . We found that during acute infection, mice exhibited a level of anemia that correlates to parasitemia ( Figures 6E and 6F ). These data suggested that anemia during the acute phase was a response to a density-dependent trypanosome factor. We reasoned that EVs would be present at concentrations dependent on parasite density, and EV-altered erythrocytes would be cleared from circulation. To test whether EV fusion causes clearance, we incubated GFP-expressing mouse erythrocytes with T. brucei EVs and intravenously injected these cells into naive mice. Similar to human erythrocytes, EVs fuse with mouse erythrocytes and acquire VSG, lipid, and increased rigidity (Figures S5A-S5D) . Clearance occurred rapidly, within 1 hr, and the remaining EV-treated erythrocytes became stable in circulation after 24 hr ( Figure 6G ). Finally, we tested whether circulating EVs stimulated a loss of erythrocytes. Injection of EVs into the tail vein of BALB/c or C57BL/6 mice re- sulted in increased erythrocyte volume ( Figure S5E ), which may be a consequence of lipid incorporation into the plasma membrane via EV-fusion, and a mean 5.3% and 10.6% decrease of erythrocytes (normalized to control injections) 1 hr post-injection ( Figure 6H ). These decreases correspond to a loss of 3.0 3 10 8 and 7.1 3 10 8 erythrocytes in BALB/C and C57BL/6 mice, respectively. Greater loss of erythrocytes in C57BL/6 is consistent with more severe anemia in trypanosome infected C57BL/6 than BALB/c mice (Magez et al., 2008) . These data combined suggest that the fusogenic properties of trypanosome EVs directly alter the physical properties of erythrocytes and likely contribute to anemia associated with both cattle and human trypanosomiasis.
Conclusions
It has become increasingly clear that most cells communicate within their immediate environment by the formation of membrane nanotube-like extensions and by the release of EVs (Remis et al., 2014; Schorey et al., 2015) . Extracellular vesicles derived from ''donor cells'' can have profound effects on ''recipient cells'' by altering gene expression and modulating signaling pathways resulting in developmental changes and modulation of immune response. EVs have also been shown to transfer virulence factors from infectious microbes to host cells, transmit infectious prion proteins and HIV, and contribute to cancer and cardiovascular disease progression (Fevrier et al., 2004; Zomer et al., 2015) . Here, we report the discovery of EVs formed by the budding and subsequent vesicularization of long membrane nanotubes from the flagellum of African trypanosomes. In these studies, we observed that T. b. brucei EVs contained several proposed trypanosome virulence factors. Furthermore, we showed that during co-cultivation EVs from T. b. rhodesiense facilitated the transfer of the virulence factor SRA to T. b. brucei where it localized within an endolysosomal compartment and conferred resistance to TLF. The formation of EVs was enhanced under stress conditions or with the addition of complement active serum, and we postulate that EV delivery of virulence factors, including but not limited to SRA, might be advantageous to the parasite in immune competent hosts. We also found that trypanosome-derived EVs are highly fusogenic with mammalian erythrocytes, resulting in physical changes to the erythrocyte membrane and rapid clearance in a mouse model. Anemia is associated with both human and cattle trypanosomiasis contributing to pathology and death.
Several proposed T. b. brucei virulence factors were found in the EV proteome, including the flagellar proteins GPI-PLC, calflagins, and metacaspase 4. While these proteins contribute to parasite virulence, their mechanisms are unknown (Emmer et al., 2010; Proto et al., 2011; Webb et al., 1997) . We found that nanotubes and EVs associated with trypanosomes have a thick VSG coat consistent with budding from the flagellar membrane; however, purified EVs have a sparse coat suggesting activation of the EV-associated GPI-PLC ( Figures  2E, S1D , and S1E). This may have implications in fusion of EVs with target membranes. T. b. brucei EVs also contained a flagellar adenylate cyclase (GRESAG4) previously proposed to increase the levels of cAMP in host immune cells, which in turn activates the host cell protein kinase A (PKA) (Salmon et al., 2012) . The activation of host cell PKA reduced production of TNF-alpha sparing trypanosomes from host innate immunity (Salmon et al., 2012) . While an appealing model, it was unclear how trypanosome adenylate cyclase could be transferred to host cells in an active state. Our discovery that highly fusogenic T. b. brucei EVs contain this enzyme raises the possibility that transfer of active GRESAG4 via EVs increased the levels of cAMP in recipient host cells.
The expression of SRA is necessary for human infectivity by T. b. rhodesiense and can be transferred to T. b. brucei during sexual crosses of the two subspecies in the tsetse fly vector (Gibson et al., 2015) . This has important implications in the generation of new genetic variants of human infective trypanosomes. Parasite co-infection in tsetse flies is dependent on dual infection of the blood meal from the mammalian host with the two subspecies. While both T. b. rhodesiense and T. b. brucei can infect cattle and wild game, it has been largely held that T. b. brucei cannot infect primates. We have shown that co-culturing the two subspecies resulted in transfer of SRA to T. b. brucei and the transmission of nonhereditary resistance to human TLF. This may have important implications in establishing dual infections in the tsetse fly and the generation of genetic diversity during epidemics of sleeping sickness when humans would represent a significant reservoir of the parasites.
Anemia is a consistent symptom of human and veterinary trypanosomiasis and a major cause of morbidity (Naessens, 2006) . The role of anemia in the pathology of trypanosomiasis cannot be overstated, and it has been argued that the ability to resist anemia is more important for survival and reproduction than the ability to control parasitemia (Naessens, 2006) . A pronounced anemia that is associated with a type 1 inflammatory response and erythrophagocytosis occurs during the acute phase of infection, whereas the significant, yet less severe anemia during the chronic phase coincides with a type 2 macrophage status and presence of the anti-inflammatory cytokine IL-10. The host responses that result in anemia are wellcharacterized (Stijlemans et al., 2015) . Our studies show that trypanosome EVs fuse with mammalian erythrocytes and cause changes to the physical properties of the membrane. We propose that our animal studies show that these changes lead to erythrophagocytosis and are the cause of anemia during acute trypanosomiasis. This discovery opens the possibility of identifying inhibitors of EV fusion with host cells and may lead to development of drugs that will spare the host from disease-induced anemia.
EXPERIMENTAL PROCEDURES
All experiments using human and animals subjects were carried out with prior approval and oversight by the Institutional Review Board. For detailed procedures, see the Supplemental Experimental Procedures.
Trypanosome Cell Culture Bloodstream form T. b. brucei Lister 427 (MiTat1.2) and T. b. rhodesiense KETRI2482 were grown in HMI-9 medium containing 10% fetal bovine serum (FBS) (Sigma) and Serum Plus supplement (SAFC Biosciences) in 5% CO 2 at 37 C.
Nanotube and Extracellular Vesicle Induction
Production of nanotubes and EVs was stimulated by stressing BF T. brucei with RNAi against the essential BF protein a-KDE1 or by the addition of complement active FBS (Sykes et al., 2015) . In all other experiments, EVs were acquired from trypanosomes grown in heat-inactivated serum or serum-free conditions (for mass spectrometry).
Extracellular Vesicle Purification T. brucei was grown in HMI-9 to a density of 1 3 10 6 cells/ml, and EVs were purified as previously described with slight modification to the protocol (Bayer-Santos et al., 2013) .
Human Erythrocytes
Erythrocytes were removed by centrifugation, washed, and stored in sterile PBS with 5% dextrose, 0.5 mM EDTA.
Microscopy
All DIC and immunofluorescence images were acquired with a Zeiss Axio Observer Z1 as previously described (Sykes et al., 2015) .
Scanning and Transmission Electron Microscopy BF T. brucei stimulated for the formation of membrane nanotubes were fixed and images were acquired with a JEOL-JEM 1210 transmission electron microscope as previously described (Sykes et al., 2015) . For SEM, 2.5% glutaraldehyde-fixed cells were dehydrated on a 0.22 mm membrane, critical point dried, sputter-coated with gold, and visualized with a Zeiss 1450EP scanning electron microscope. Three-dimensional reconstruction of serial TEM sections was carried out using tools available in the IMOD 4.7 software package (Kremer et al., 1996) .
Nanoparticle Tracking Analysis
The concentration and diameter of freshly prepared EVs from 2 3 10 8 trypanosomes was determined by analysis with a NanoSight NS300 (Malvern). Fifteen hundred frames were acquired at 25 frames per second at 25 C.
SDS-PAGE and Western Blotting
Total cell and purified EV proteins were fractionated by reducing SDS-PAGE and western blotted as previously described using 5 3 10 5 BF trypanosomes or EVs purified from 2 3 10 6 cells (Sykes et al., 2015) .
SRA Transfer Assay
For flow cytometry, T. brucei was incubated with EVs for 1 hr at 37 C. T. brucei, T. brucei SRA-Ty , and EV-treated T. brucei cells were chilled washed with 13 PBS, fixed with 0.05% paraformaldehyde, and an aliquot was permeabilized with ice cold 0.1% Triton X-100. For microscopy T. brucei was incubated with EVs for 1 hr at 3 C or 30 min at 37 C. ConA was added, and cells were prepared for fluorescence microscopy.
Overnight Survival Assay
Co-cultured or transwell co-cultured trypanosomes were treated with TLF for 24 hr at 37 C. Trypanosomes were incubated with purified EVs for 1 hr and then treated with TLF for 24 hr at 37 C. After treatment, surviving cells were counted by phase-contrast microscopy and compared against non-TLFtreated cultures.
EV Protein Transfer
Purified EVs were labeled with an Alexa-594 labeling kit (Life Technologies) and 1 3 10 7 cell equivalents were added to 1 3 10 8 T. brucei at 3 C. After washing, cells were warmed to 37 C and prepared for microscopy (Sykes et al., 2015) .
Membrane Fusion Assay
Vesicle fusion was measured essentially as described by Vidal and Hoekstra (1995) .
Transwell Co-culture T. brucei was co-cultured with T. brucei SRA-Ty or T. b. rhodesiense in 0.2 mm transwell culture plates. Cells were co-cultured for 24 hr then split 1/10 and treated with TLF for an overnight survival assay. For erythrocyte co-culture, T. brucei was inoculated with mouse or human erythrocytes in transwell plates.
Flow Cytometry Analysis of Lipid and VSG Transfer
After co-culture with trypanosomes, erythrocytes were washed prior to analysis. Samples analyzed for lipid transfer by R18 staining were directly analyzed while erythrocytes analyzed for VSG transfer were first treated using the protocol for fluorescence microscopy staining. All samples were then analyzed using a CyAn ADP Analyzer.
Osmotic Lysis Assay
Freshly collected human erythrocytes were resuspended in PBS and incubated with EVs. Erythrocytes were incubated in NaCl solutions, pelleted and the absorbance of the supernatant was read. Complete lysis was achieved by incubation in deionized H 2 O.
Laurdan Spectral Analysis
Freshly collected human or mouse erythrocytes were resuspended in and incubated with EVs for 30 min. Erythrocytes were washed, labeled with Laurdan for 30 min, washed three times with PBS, and spectra recorded with the Perkin Elmer Life Sciences LS-55 luminescent spectrofluorometer.
Trypanosome Infections and EV Treatments
Trypanosome infections were initiated by intraperitoneal injection of T. b. brucei Lister 427-221 parasites in retired breeder female BALB/c mice (Jackson Laboratory). Parasitemias were determined by the matching method (Herbert and Lumsden, 1976) . For ex vivo EV-treatment, erythrocytes from 10-week-old mice expressing GFP from a ubiquitin promoter (C57BL/6-Tg(UBC-GFP)30Scha/J) (Jackson Laboratory) were collected and incubated with or without EVs. Erythrocytes were injected into the tail vein of naive C57BL/6J mice. Whole blood collected from the tail vein was analyzed by flow cytometry, and GFP-positive erythrocytes were quantified from the ratio of labeled to unlabeled erythrocytes.
For direct EV injections, wild-type BALB/c and C57BL/6J mice were injected intravenously (tail vein) with EVs freshly prepared in PBS. Control mice were injected with an equal volume of PBS. Erythrocyte counts were determined via Coulter counting.
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